Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis

Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis

Introduction: Risk of adverse effects and exacerbation in autoimmune neurological conditions (ANC)are frequently cited reasons for COVID-19 vaccine hesitancy. This study evaluates the ANC safety of COVID-19 vaccines in the real world. Methods: Electronic databases were searched to identify studies r...

Full description

Bibliographic Details
Main Authors:	Fan Ning, Xiang-qi Cao, Qing-qing Wang, Zhu-yi Li, Zhe Ruan, Ting Chang
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Heliyon
Subjects:	SARS-CoV-2 vaccine Autoimmune neurological conditions Safety Vaccination hesitancy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023111522

Similar Items

The COVID‐19 vaccine: Attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases
by: Jiali Chen, et al.
Published: (2022-06-01)

Safety of Vaccination within First Year of Life—The Experience of One General Medicine Center
by: Claudia Felicia Pop, et al.
Published: (2023-01-01)

Relationship between SARS-COV-2 And autoimmune neurological diseases
by: A. I. Vlasenko, et al.
Published: (2022-07-01)

Factors associated with SARS-CoV-2 vaccine hesitancy after stroke: a cross-sectional study
by: Peng Hu, et al.
Published: (2024-05-01)

Adherence and Reactogenicity to Vaccines against SARS-COV-2 in 285 Patients with Neuropathy: A Multicentric Study
by: Salvatore Iacono, et al.
Published: (2022-10-01)

Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?
by: Ioannis P. Trontzas, et al.
Published: (2022-12-01)

COVID-19 Vaccination Hesitancy in Autoimmune Disease Patients: Policy Action and Ethical Considerations
by: Nardeen Shafik, et al.
Published: (2023-07-01)

In silico design of multiepitope vaccine candidate against SARS CoV and CoV2
by: Krupanidhi Sreerama
Published: (2020-12-01)

Development of SARS-COV-2 vaccines and their mechanisms of action: An approach to change the Africans perspectives on COVID-19 vaccines
by: Sunday Zeal Bala, et al.
Published: (2021-10-01)

Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE
by: Faheem Ahamed, et al.
Published: (2021-08-01)

A Narrative Review of Neurological Complications of SARS-CoV-2 Vaccination
by: Parmod K. Bithal, et al.
Published: (2024-03-01)

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
by: Cielo García-Montero, et al.
Published: (2021-04-01)

Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
by: Hui Xuan Lim, et al.
Published: (2021-11-01)

Exacerbation of Autoimmune Hepatitis following Inactivated SARS-CoV-2 Vaccination
by: Siwanon Nawalerspanya, et al.
Published: (2024-05-01)

Vaccinations and Autoimmune Diseases
by: Bianca Olivieri, et al.
Published: (2021-07-01)

COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity
by: Ying Liu, et al.
Published: (2021-12-01)

Perceptions of vaccine safety and hesitancy among incarcerated adults and correctional staff in the rural midwest
by: Kelli E. Canada, et al.
Published: (2023-04-01)

Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study
by: Zhe Ruan, et al.
Published: (2023-05-01)

Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination
by: Valentina Gerussi, et al.
Published: (2021-02-01)

Attitudes toward the SARS-CoV-2 and Influenza Vaccination in the Metropolitan Cities of Bologna and Palermo, Italy
by: Marco Montalti, et al.
Published: (2021-10-01)

Alteration in vaccination rates and an evaluation of physicians’ perceptions of the possible impact of the SARS-CoV-2 pandemic on childhood vaccinations in Ankara, Turkey
by: Ateş Kara, et al.
Published: (2021-10-01)

Maternal Vaccination in Uganda: Exploring Pregnant Women, Community Leaders and Healthcare Workers’ Perceptions
by: Phiona Nalubega, et al.
Published: (2021-05-01)

Factors Influencing SARS-CoV-2 Vaccine Acceptance and Hesitancy in a Population-Based Sample in Italy
by: Marco Del Riccio, et al.
Published: (2021-06-01)

Assessing SARS-CoV-2 vaccine hesitancy among the people living with and without HIV from May to September 2022 in Blantyre, Malawi
by: Chifundo Mchawa, et al.
Published: (2023-08-01)

Attitudes, perceptions, and experiences of Western Australians towards vaccine safety surveillance systems following COVID-19 vaccines: A qualitative descriptive study
by: Denis Liu Shiu Cheong, et al.
Published: (2024-08-01)

Psychological reactance impacts ratings of pediatrician vaccine-related communication quality, perceived vaccine safety, and vaccination priority among U.S. parents
by: Stacey R. Finkelstein, et al.
Published: (2020-05-01)

Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries
by: Analía Urueña, et al.
Published: (2023-10-01)

Vaccine hesitancy and its determinants among Arab parents: a cross-sectional survey in the United Arab Emirates
by: Ahmed R. Alsuwaidi, et al.
Published: (2020-12-01)

Determinants of COVID-19 vaccine behaviour intentions among the youth in Kenya: a cross-sectional study
by: Joachim O. Osur, et al.
Published: (2022-06-01)

Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis
by: Katja Burian, et al.
Published: (2024-05-01)

Vaccine Hesitancy in China: A Qualitative Study of Stakeholders’ Perspectives
by: Ronghui Yang, et al.
Published: (2020-11-01)

Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study
by: Alberto Vogrig, et al.
Published: (2024-02-01)

Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
by: Utkarsh Srivastava, et al.
Published: (2022-10-01)

SARS-CoV-2 and influenza vaccine hesitancy during the COVID-19 pandemic in a dynamic perspective
by: Valentina Gerussi, et al.
Published: (2024-12-01)

Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy
by: Marco Montalti, et al.
Published: (2021-04-01)

Vaccine safety – is the SARS-CoV-2 vaccine any different?
by: Noam Tau, et al.
Published: (2021-05-01)

SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
by: Zhihua Fan, et al.
Published: (2022-09-01)

Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal
by: Carolyne Nasimiyu, et al.
Published: (2022-12-01)

Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases
by: Chao Cao, et al.
Published: (2022-05-01)

Can Vaccination Trigger Autoimmune Disorders? A Meta-Analysis
by: Marek Petráš, et al.
Published: (2021-07-01)